OTC · Health care

PureTech Health plc (PRTCY)

PureTech Health plc reported revenue of $4.8M in fiscal 2024, up 45.0% from a year earlier. Net income was $53.5M, a net margin of 1,108.3%. In fiscal 2024 capital spending exceeded operating cash flow by $134.4M. At December 31, 2024 it held $280.6M in cash. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on April 29, 2026.

Watch PRTCY in 60 seconds

Price

$15.15

-1.56% on the day · September 25, 2026

52-week range $14.40 to $19.92

Revenue (FY2024)

$4.8M

+45.0% year on year

Net margin

1,108.3%

What PureTech Health plc does

PureTech Health plc is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on OTC under the ticker PRTCY.

Revenue and profit by year

Revenue

Net income

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal year	Revenue	Operating income	Net income	Diluted EPS	Free cash flow
2024	$4.8M	-$136.1M	$53.5M	$0.21	-$134.4M
2023	$3.3M	-$146.2M	-$65.7M	-$0.24	-$106M
2022	$15.6M	-$197.8M	-$50.4M	-$0.18	-$181M
2021	$17.4M	-$150.3M	-$60.6M	-$0.21	-$163.8M
2020	$11.8M	-$119.5M	$6M	$0.02	-$137M
2020	$9.8M	-$135.4M	$421.1M	$1.44	-$110.3M

Full financial statements: income, balance sheet and cash flow

Where PRTCY ranks in Health care

Revenue$4.8M

#562 of 742 in Health care · Bottom 24%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What PureTech Health plc has filed recently, newest first. Each links to the original document on SEC EDGAR.

May 22, 2026
Form F-6 POS filing F-6 POS
May 21, 2026
Securities offering prospectus 424B3
May 21, 2026
Form 15F-12B filing 15F-12B
May 11, 2026
Form 25 filing 25
May 11, 2026
Passive stake changed SCHEDULE 13G/A
May 1, 2026
Foreign issuer update 6-K
April 29, 2026
Passive stake (5% or more) SCHEDULE 13G
April 29, 2026
Annual report (foreign issuer) 20-F · period to December 31, 2025
April 29, 2026
Foreign issuer update 6-K
April 29, 2026
Foreign issuer update 6-K

Recent insider filings (Forms 3, 4 and 144): 8, the latest on April 30, 2026. Insider transactions on SEC

Who owns PRTCY

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

Holder	Of class	Shares	Filed
Tang Capital Management, LLC13G, passive with 5 related filers	5.19%	12,635,782	April 29, 2026

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

We have not read this company's Form 4 filings yet.

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about PRTCY

What does PureTech Health plc do?

PureTech Health plc is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on OTC under the ticker PRTCY.

Is PureTech Health plc profitable?

Yes. In fiscal 2024 it reported net income of $53.5M on revenue of $4.8M, a net margin of 1,108.3%.

How much revenue does PureTech Health plc make?

In fiscal 2024 PureTech Health plc reported revenue of $4.8M. That is 45.0% more than a year earlier.

When did PureTech Health plc last report?

Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on April 29, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the form F-6 POS filing from May 22, 2026.

Similar companies

TAK

Takeda Pharmaceutical Co Ltd

Compare PRTCY with

Compare PRTCY with any company

Follow PRTCY

Get an email when PureTech Health plc files with the SEC: results, executive changes, material agreements and annual reports.

Follow PRTCY: get an email when it files

Where the numbers come from

Financial figures are the values PureTech Health plc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.